2020
DOI: 10.2147/ijn.s249240
|View full text |Cite
|
Sign up to set email alerts
|

<p>ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy</p>

Abstract: Background and Objective: Cancer cells accumulate high concentrations of reactive oxygen species as a result of their faster and uninhibited metabolic activity. Cancer chemotherapeutic agents release an excess of severe adverse reactions as a result of targeting normal cells. This demands an improvement in targeted drug-delivery systems to selectively discharge anticancer drugs in the vicinity of such highly metabolically and mitotically active cells. Materials and Methods: Here, magnetic nanoparticles were sy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(15 citation statements)
references
References 52 publications
0
15
0
Order By: Relevance
“…This findings also agreed with previous studies that the Fe 3 O 4 composite can be used as an effective inhibitor of antibiotic resistance in medicine, including nanoparticles carrying chemotherapeutic agents used in cancer treatment; our result suggested that the good efficacy might be due to improving the ROS level. 43–45 Thus, we believed that the combination of a conventional cancer drug Ara-C and the IONPs to target upregulation of ROS would be a better approach than using chemotherapeutic agents alone to improve drug-sensitivity for treating AML patients.…”
Section: Resultsmentioning
confidence: 99%
“…This findings also agreed with previous studies that the Fe 3 O 4 composite can be used as an effective inhibitor of antibiotic resistance in medicine, including nanoparticles carrying chemotherapeutic agents used in cancer treatment; our result suggested that the good efficacy might be due to improving the ROS level. 43–45 Thus, we believed that the combination of a conventional cancer drug Ara-C and the IONPs to target upregulation of ROS would be a better approach than using chemotherapeutic agents alone to improve drug-sensitivity for treating AML patients.…”
Section: Resultsmentioning
confidence: 99%
“…211 Anticancer drugs are efficient for neutralizing cancer cells 212 but are harmful, which reduces their therapeutic use. 213 Many techniques for cancer treatment such as radiotherapy, surgery and chemotherapy have harmful side effects. 214 Therefore, magnetic nanoparticles are applied due to their ability to perform at the molecular and cellular levels of biological interactions and possess superparamagnetic properties.…”
Section: Application Of Magnetic Chitosan In Cancer Diagnosismentioning
confidence: 99%
“…Functionalized Fe 3 O 4 nanoparticles released 90% of 5-fluorouracil in response to H 2 O 2 , causing irreversible damage to A549 and HeLa S3 cells. 70 Chitosan-coated MCs were cross-linked with O 6 -benzylguanine to treat temozolomide-resistant glioblastoma models in vitro (GBM6) and in vivo (GBM6 tumors in nude mice). A redox-responsive shell was modified with chlorotoxin to improve MCs targeting to the tumor cells, in which the nanoparticle shell could be reduced by altered redox metabolism.…”
Section: Remote Control Of Redox Effectsmentioning
confidence: 99%